Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2491 (108th)

Greater Access to Affordable Pharmaceuticals Act

referredUnited States· United States Congress· EN

Introduced

17 June 2003

Last action

25 June 2003 · Referred

Status

Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.

Sponsors

Rep. Emerson, Jo Ann [R-MO-8], Sen. Brown, Sherrod [D-OH], Rep. Wamp, Zach [R-TN-3], Rep. Waxman, Henry A. [D-CA-33], Rep. Bono, Mary [R-CA-44], Rep. Edwards, Chet [D-TX-17], Rep. Gutknecht, Gil [R-MN-1], Rep. Emanuel, Rahm [D-IL-5], Rep. Northup, Anne M. [R-KY-3], Rep. Pallone, Frank [D-NJ-6], Rep. Bradley, Jeb [R-NH-1], Rep. Lowey, Nita M. [D-NY-17], Rep. Bereuter, Doug [R-NE-1], Rep. Serrano, Jose E. [D-NY-15], Rep. Kingston, Jack [R-GA-1], Rep. Wexler, Robert [D-FL-19], Rep. Janklow, William J. [R-SD-At Large], Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Osborne, Tom [R-NE-3], Rep. Langevin, James R. [D-RI-2], Rep. Calvert, Ken [R-CA-41], Rep. Cooper, Jim [D-TN-5], Sen. Markey, Edward J. [D-MA], Rep. Allen, Thomas H. [D-ME-1], Rep. Burton, Dan [R-IN-5], Rep. Nadler, Jerrold [D-NY-12], Rep. Mollohan, Alan B. [D-WV-1], Rep. DeLauro, Rosa L. [D-CT-3], Sen. Sanders, Bernard [I-VT], Rep. Owens, Major R. [D-NY-11], Rep. Kildee, Dale E. [D-MI-5], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Smith, Nick [R-MI-7], Rep. Strickland, Ted [D-OH-6]

Subjects

Healthcare

Source updated

18 August 2025

Healthcare

Summary

Greater Access to Affordable Pharmaceuticals Act - Amends the Federal Food, Drug, and Cosmetic Act to: (1) limit a brand name drug manufacturer to one Food and Drug Administration (FDA) 30-month stay of competition in a patent infringement suit against a generic drug applicant; (2) permit a generic applicant being sued to file a counterclaim to correct or delete patent information; (3) limit damages that a brand name manufacturer may recover in an instance where such manufacturer failed to file certain patent information; (4) permit a generic drug applicant to seek declaratory judgment regarding patent infringement prior to marketing a drug; (5) forfeit the180-day market exclusivity period for a first generic drug applicant to a subsequent generic applicant if the first applicant engages in certain activities which impede such drug's timely marketing; and (6) permit alternative means to determine bioequivalence for drugs that are not absorbed into the bloodstream.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 17 June 2003

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 17 June 2003

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 17 June 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 17 June 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 24 June 2003

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 25 June 2003

    Referred

    Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 17 June 2003

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 17 June 2003

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 17 June 2003

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.